296 related articles for article (PubMed ID: 26523672)
1. miR-210 and hypoxic microvesicles: Two critical components of hypoxia involved in the regulation of killer cells function.
Noman MZ; Janji B; Berchem G; Chouaib S
Cancer Lett; 2016 Sep; 380(1):257-62. PubMed ID: 26523672
[TBL] [Abstract][Full Text] [Related]
2. Tumor Immune Microenvironment and Its Related miRNAs in Tumor Progression.
Xing Y; Ruan G; Ni H; Qin H; Chen S; Gu X; Shang J; Zhou Y; Tao X; Zheng L
Front Immunol; 2021; 12():624725. PubMed ID: 34084160
[TBL] [Abstract][Full Text] [Related]
3. The Antitumor Cytotoxic Response: If the Killer Cells Play the Music, the Microenvironmental Hypoxia Plays the Tune.
Chouaib S
Crit Rev Immunol; 2020; 40(2):157-166. PubMed ID: 32749093
[TBL] [Abstract][Full Text] [Related]
4. Microenvironmental hypoxia orchestrating the cell stroma cross talk, tumor progression and antitumor response.
Noman MZ; Messai Y; Carré T; Akalay I; Méron M; Janji B; Hasmim M; Chouaib S
Crit Rev Immunol; 2011; 31(5):357-77. PubMed ID: 22142164
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-inducible miR-210 regulates the susceptibility of tumor cells to lysis by cytotoxic T cells.
Noman MZ; Buart S; Romero P; Ketari S; Janji B; Mari B; Mami-Chouaib F; Chouaib S
Cancer Res; 2012 Sep; 72(18):4629-41. PubMed ID: 22962263
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathways: tumor-derived microvesicles and their interactions with immune cells in vivo.
Pucci F; Pittet MJ
Clin Cancer Res; 2013 May; 19(10):2598-604. PubMed ID: 23426276
[TBL] [Abstract][Full Text] [Related]
7. Hypoxic Melanoma Cells Deliver microRNAs to Dendritic Cells and Cytotoxic T Lymphocytes through Connexin-43 Channels.
Tittarelli A; Navarrete M; Lizana M; Hofmann-Vega F; Salazar-Onfray F
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066331
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia.
Noman MZ; Hasmim M; Messai Y; Terry S; Kieda C; Janji B; Chouaib S
Am J Physiol Cell Physiol; 2015 Nov; 309(9):C569-79. PubMed ID: 26310815
[TBL] [Abstract][Full Text] [Related]
9. Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance.
Khalaf K; Hana D; Chou JT; Singh C; Mackiewicz A; Kaczmarek M
Front Immunol; 2021; 12():656364. PubMed ID: 34122412
[TBL] [Abstract][Full Text] [Related]
10. A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells.
Barsoum IB; Smallwood CA; Siemens DR; Graham CH
Cancer Res; 2014 Feb; 74(3):665-74. PubMed ID: 24336068
[TBL] [Abstract][Full Text] [Related]
11. Single-Cell RNA Sequencing of Tumor-Infiltrating NK Cells Reveals that Inhibition of Transcription Factor HIF-1α Unleashes NK Cell Activity.
Ni J; Wang X; Stojanovic A; Zhang Q; Wincher M; Bühler L; Arnold A; Correia MP; Winkler M; Koch PS; Sexl V; Höfer T; Cerwenka A
Immunity; 2020 Jun; 52(6):1075-1087.e8. PubMed ID: 32445619
[TBL] [Abstract][Full Text] [Related]
12. Natural Killer Cell-Derived Extracellular Vesicles: Novel Players in Cancer Immunotherapy.
Wu F; Xie M; Hun M; She Z; Li C; Luo S; Chen X; Wan W; Wen C; Tian J
Front Immunol; 2021; 12():658698. PubMed ID: 34093547
[TBL] [Abstract][Full Text] [Related]
13. Animal models for studying tumor microenvironment (TME) and resistance to lymphocytic infiltration.
Yamaguchi R; Perkins G
Cancer Biol Ther; 2018; 19(9):745-754. PubMed ID: 29723108
[TBL] [Abstract][Full Text] [Related]
14. Tumor hypoxia represses γδ T cell-mediated antitumor immunity against brain tumors.
Park JH; Kim HJ; Kim CW; Kim HC; Jung Y; Lee HS; Lee Y; Ju YS; Oh JE; Park SH; Lee JH; Lee SK; Lee HK
Nat Immunol; 2021 Mar; 22(3):336-346. PubMed ID: 33574616
[TBL] [Abstract][Full Text] [Related]
15. Cancer-derived exosomic microRNAs shape the immune system within the tumor microenvironment: State of the art.
Fanini F; Fabbri M
Semin Cell Dev Biol; 2017 Jul; 67():23-28. PubMed ID: 27956165
[TBL] [Abstract][Full Text] [Related]
16. Functional and metabolic targeting of natural killer cells to solid tumors.
Wang J; Matosevic S
Cell Oncol (Dordr); 2020 Aug; 43(4):577-600. PubMed ID: 32488848
[TBL] [Abstract][Full Text] [Related]
17. Myeloid-derived suppressor cells and tumor escape from immune surveillance.
Umansky V; Blattner C; Fleming V; Hu X; Gebhardt C; Altevogt P; Utikal J
Semin Immunopathol; 2017 Apr; 39(3):295-305. PubMed ID: 27787613
[TBL] [Abstract][Full Text] [Related]
18. miRNA Deregulation in Cancer Cells and the Tumor Microenvironment.
Rupaimoole R; Calin GA; Lopez-Berestein G; Sood AK
Cancer Discov; 2016 Mar; 6(3):235-46. PubMed ID: 26865249
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of tumor cells escaping from immune surveillance of NK cells.
Ge Z; Wu S; Zhang Z; Ding S
Immunopharmacol Immunotoxicol; 2020 Jun; 42(3):187-198. PubMed ID: 32223464
[TBL] [Abstract][Full Text] [Related]
20. Natural Killer Cell-Derived Vesicular miRNAs: A New Anticancer Approach?
Fabbri M
Cancer Res; 2020 Jan; 80(1):17-22. PubMed ID: 31672842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]